Rimifon



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Renal Tuberculosis 100.0%
Visual Disturbance 100.0%
Secondary
Tuberculosis 30.1%
Hiv Infection 17.3%
Drug Use For Unknown Indication 13.4%
Pulmonary Tuberculosis 6.2%
Disseminated Tuberculosis 4.5%
Prophylaxis 3.7%
Antifungal Prophylaxis 3.3%
Meningitis Aseptic 3.1%
Product Used For Unknown Indication 2.9%
Bone Tuberculosis 1.8%
Maternal Exposure During Pregnancy 1.8%
Antibiotic Prophylaxis 1.7%
Lymph Node Tuberculosis 1.4%
Meningitis Tuberculous 1.4%
Renal Transplant 1.4%
Hypertension 1.3%
Insomnia 1.3%
Maternal Exposure Timing Unspecified 1.3%
Infection 1.1%
Peritoneal Tuberculosis 1.0%
Vomiting 14.8%
Hepatitis Fulminant 7.4%
Neutropenia 7.4%
Immune Reconstitution Syndrome 6.5%
Electroencephalogram Abnormal 5.6%
Joint Effusion 5.6%
Pancreatitis Acute 5.6%
Pyrexia 5.6%
Toxic Skin Eruption 4.6%
Transaminases Increased 4.6%
Hypoglycaemia 3.7%
Jaundice 3.7%
Rash 3.7%
Rash Maculo-papular 3.7%
Renal Failure Acute 3.7%
Hepatitis Cholestatic 2.8%
Nervous System Disorder 2.8%
Renal Tubular Disorder 2.8%
Thrombocytopenia 2.8%
Tuberculosis Liver 2.8%
Concomitant
Tuberculosis 23.9%
Hiv Infection 23.2%
Pulmonary Tuberculosis 12.1%
Product Used For Unknown Indication 7.7%
Drug Use For Unknown Indication 4.9%
Prophylaxis 4.4%
Mycobacterium Avium Complex Infection 3.1%
Disseminated Tuberculosis 2.5%
Acquired Immunodeficiency Syndrome 2.4%
Rheumatoid Arthritis 2.3%
Lymphoma 1.8%
Anaemia 1.7%
Antifungal Prophylaxis 1.7%
Diffuse Large B-cell Lymphoma 1.5%
Mycobacterial Infection 1.3%
B-cell Lymphoma 1.2%
Hypertension 1.2%
Cytomegalovirus Infection 1.1%
Lung Transplant 1.1%
Pain 1.1%
Pyrexia 18.5%
Renal Failure 9.2%
Tuberculosis 9.2%
Renal Failure Acute 8.4%
Vomiting 7.6%
Clostridium Difficile Colitis 5.0%
Subdural Haematoma 5.0%
Hepatic Enzyme Increased 4.2%
Urticaria 4.2%
Drug Eruption 3.4%
Viral Infection 3.4%
Hepatic Failure 2.5%
Hepatitis Fulminant 2.5%
Impaired Gastric Emptying 2.5%
Lymphadenopathy 2.5%
Rash 2.5%
Renal Tubular Necrosis 2.5%
Splenomegaly 2.5%
Vertigo 2.5%
Cholestasis 1.7%